LALPATHLAB Valuation

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;padding-top: 25px;;'>DL</div>
Do you want to know what the current value of Dr Lal Pathlabs is today? Dr Lal Pathlabs latest Real Value cannot be determined due to lack of data. The recent price of Dr Lal Pathlabs is 0.0. Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Our model computes the value of Dr Lal Pathlabs from reviewing the firm fundamentals such as current valuation of 85.17 B, return on asset of 15.94 %, and price to sales of 7.46 X as well as analyzing its technical indicators and Probability Of Bankruptcy. In general, we advise locking in undervalued equities and disposing overvalued equities since, in the future, asset prices and their ongoing real values will draw towards each other.

Search Valuation

 
Refresh
Dr Lal Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Dr Lal's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.

Dr Lal Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Dr Lal's current stock value. Our valuation model uses many indicators to compare Dr Lal value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Dr Lal competition to find correlations between indicators driving Dr Lal's intrinsic value. More Info.
Dr Lal Pathlabs is currently regarded as number one stock in price to sales category among related companies. It is currently regarded as number one stock in price to earning category among related companies reporting about  6.01  of Price to Earning per Price to Sales.
Follow Benchmarks with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Check out Stocks Correlation. Please also try Equity Valuation module to check real value of public entities based on technical and fundamental data.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page